PUBLISHER: 360iResearch | PRODUCT CODE: 1598480
PUBLISHER: 360iResearch | PRODUCT CODE: 1598480
Toxicity Testing Outsourcing Market by Method (In-Vitro toxicity testing, In-Vivo toxicity testing), Practice Type (Good Laboratory Practices (GLP), Non-GLP), End-Use - Global Forecast 2025-2030
The Toxicity Testing Outsourcing Market was valued at USD 3.97 billion in 2023, expected to reach USD 4.31 billion in 2024, and is projected to grow at a CAGR of 9.03%, to USD 7.28 billion by 2030.
The scope of toxicity testing outsourcing involves contracting external laboratories and service providers to conduct tests assessing the safety and potential harmful effects of chemicals, pharmaceuticals, and other substances. This approach is necessitated by the need for organizations to comply with stringent regulatory requirements, manage costs, and access specialized expertise not available in-house. It finds application across industries such as pharmaceuticals, agrochemicals, biotechnology, and consumer goods, with end-use sectors including pharmaceuticals, cosmetics, food and beverage, and environmental analysis. Market growth is driven by increasing R&D expenditures, technological advancements in testing methodologies, and heightened awareness of chemical safety and environmental impact. Additionally, the move towards animal-free testing and emphasis on predictive toxicity and high-throughput screening open fresh avenues for innovation and ongoing research. Opportunities also arise from expanding markets in emerging economies where regulatory frameworks are becoming more stringent, thereby fueling demand for expert services.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 3.97 billion |
| Estimated Year [2024] | USD 4.31 billion |
| Forecast Year [2030] | USD 7.28 billion |
| CAGR (%) | 9.03% |
However, several challenges impede market expansion. These include regulatory hindrances, ethical concerns regarding animal testing, and the high cost of advanced testing technologies. Moreover, varying regional regulations can create complexities for global operations, necessitating adaptable and compliant testing solutions across different jurisdictions. Despite these challenges, investing in technology-driven innovations, such as artificial intelligence and machine learning integration in toxicity prediction models and expanding partnerships and collaborations, can catalyze market growth.
Firms should prioritize innovative development in in vitro, in silico, and alternative testing methods, energy-efficient and cost-effective processes, and use of biotechnology in toxicity forecasting to edge ahead. The market is dynamic, evolving with technological progress and shifting regulatory landscapes, thus emphasizing the need for continuous monitoring and adaptation to identify emerging trends and legislative changes promptly. Engaging in research consortia can further facilitate knowledge sharing and drive industry-standard advancements across networks, ensuring sustained business growth.
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Toxicity Testing Outsourcing Market
The Toxicity Testing Outsourcing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Rising ethical issues about animal testing
- Increasing focus on drug discovery and personalized medicine
- Growing number of toxicity databases
- Market Restraints
- Lack of standards to establish intricacies of in-vivo conditions
- Market Opportunities
- Growing acceptance of toxicity testing services with the evolution of 3D cell culture systems
- Extensive adoption of toxicology assays attributed to safety time-saving parameters
- Market Challenges
- Lack of trained expertise for the toxicity testing procedure
Porter's Five Forces: A Strategic Tool for Navigating the Toxicity Testing Outsourcing Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Toxicity Testing Outsourcing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Toxicity Testing Outsourcing Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Toxicity Testing Outsourcing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Toxicity Testing Outsourcing Market
A detailed market share analysis in the Toxicity Testing Outsourcing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Toxicity Testing Outsourcing Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Toxicity Testing Outsourcing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Toxicity Testing Outsourcing Market
A strategic analysis of the Toxicity Testing Outsourcing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Toxicity Testing Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Biognosys AG, BioIVT, LLC, Catalent, Inc., Charles River Laboratories International, Inc., Danaher Corporation, Eagle Analytical, Eurofins Scientific Limited, Evotec SE, Laboratory Corporation of America Holdings, Lonza Group Ltd., Merck KGaA, Perkinelmer Inc., Promega Corporation, Qiagen N.V., Quest Diagnostics Incorporated, SGS S.A., and Thermo Fisher Scientific, Inc..
Market Segmentation & Coverage
This research report categorizes the Toxicity Testing Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Method, market is studied across In-Vitro toxicity testing and In-Vivo toxicity testing.
- Based on Practice Type, market is studied across Good Laboratory Practices (GLP) and Non-GLP.
- Based on End-Use, market is studied across Academic & Research Institutes and Pharmaceutical & Biopharmaceutical Companies.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising ethical issues about animal testing
- 5.1.1.2. Increasing focus on drug discovery and personalized medicine
- 5.1.1.3. Growing number of toxicity databases
- 5.1.2. Restraints
- 5.1.2.1. Lack of standards to establish intricacies of in-vivo conditions
- 5.1.3. Opportunities
- 5.1.3.1. Growing acceptance of toxicity testing services with the evolution of 3D cell culture systems
- 5.1.3.2. Extensive adoption of toxicology assays attributed to safety time-saving parameters
- 5.1.4. Challenges
- 5.1.4.1. Lack of trained expertise for the toxicity testing procedure
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Toxicity Testing Outsourcing Market, by Method
- 6.1. Introduction
- 6.2. In-Vitro toxicity testing
- 6.3. In-Vivo toxicity testing
7. Toxicity Testing Outsourcing Market, by Practice Type
- 7.1. Introduction
- 7.2. Good Laboratory Practices (GLP)
- 7.3. Non-GLP
8. Toxicity Testing Outsourcing Market, by End-Use
- 8.1. Introduction
- 8.2. Academic & Research Institutes
- 8.3. Pharmaceutical & Biopharmaceutical Companies
9. Americas Toxicity Testing Outsourcing Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Toxicity Testing Outsourcing Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Toxicity Testing Outsourcing Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. Abbott Laboratories
- 2. Agilent Technologies, Inc.
- 3. Bio-Rad Laboratories, Inc.
- 4. Biognosys AG
- 5. BioIVT, LLC
- 6. Catalent, Inc.
- 7. Charles River Laboratories International, Inc.
- 8. Danaher Corporation
- 9. Eagle Analytical
- 10. Eurofins Scientific Limited
- 11. Evotec SE
- 12. Laboratory Corporation of America Holdings
- 13. Lonza Group Ltd.
- 14. Merck KGaA
- 15. Perkinelmer Inc.
- 16. Promega Corporation
- 17. Qiagen N.V.
- 18. Quest Diagnostics Incorporated
- 19. SGS S.A.
- 20. Thermo Fisher Scientific, Inc.
LIST OF FIGURES
- FIGURE 1. TOXICITY TESTING OUTSOURCING MARKET RESEARCH PROCESS
- FIGURE 2. TOXICITY TESTING OUTSOURCING MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 13. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 15. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. TOXICITY TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 21. TOXICITY TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. TOXICITY TESTING OUTSOURCING MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. TOXICITY TESTING OUTSOURCING MARKET DYNAMICS
- TABLE 7. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN-VITRO TOXICITY TESTING, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN-VIVO TOXICITY TESTING, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GOOD LABORATORY PRACTICES (GLP), BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY NON-GLP, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 17. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 18. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 19. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 20. ARGENTINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 21. ARGENTINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 22. ARGENTINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 23. BRAZIL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 24. BRAZIL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 25. BRAZIL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 26. CANADA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 27. CANADA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 28. CANADA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 29. MEXICO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 30. MEXICO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 31. MEXICO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 32. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 33. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 34. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 35. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 36. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 37. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 38. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 39. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 40. AUSTRALIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 41. AUSTRALIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 42. AUSTRALIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 43. CHINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 44. CHINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 45. CHINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 46. INDIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 47. INDIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 48. INDIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 49. INDONESIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 50. INDONESIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 51. INDONESIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 52. JAPAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 53. JAPAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 54. JAPAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 55. MALAYSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 56. MALAYSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 57. MALAYSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 58. PHILIPPINES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 59. PHILIPPINES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 60. PHILIPPINES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 61. SINGAPORE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 62. SINGAPORE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 63. SINGAPORE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 64. SOUTH KOREA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 65. SOUTH KOREA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 66. SOUTH KOREA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 67. TAIWAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 68. TAIWAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 69. TAIWAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 70. THAILAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 71. THAILAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 72. THAILAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 73. VIETNAM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 74. VIETNAM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 75. VIETNAM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 76. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 77. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 78. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 79. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 80. DENMARK TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 81. DENMARK TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 82. DENMARK TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 83. EGYPT TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 84. EGYPT TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 85. EGYPT TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 86. FINLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 87. FINLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 88. FINLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 89. FRANCE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 90. FRANCE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 91. FRANCE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 92. GERMANY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 93. GERMANY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 94. GERMANY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 95. ISRAEL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 96. ISRAEL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 97. ISRAEL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 98. ITALY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 99. ITALY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 100. ITALY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 101. NETHERLANDS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 102. NETHERLANDS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 103. NETHERLANDS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 104. NIGERIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 105. NIGERIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 106. NIGERIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 107. NORWAY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 108. NORWAY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 109. NORWAY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 110. POLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 111. POLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 112. POLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 113. QATAR TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 114. QATAR TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 115. QATAR TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 116. RUSSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 117. RUSSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 118. RUSSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 119. SAUDI ARABIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 120. SAUDI ARABIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 121. SAUDI ARABIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 122. SOUTH AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 123. SOUTH AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 124. SOUTH AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 125. SPAIN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 126. SPAIN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 127. SPAIN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 128. SWEDEN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 129. SWEDEN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 130. SWEDEN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 131. SWITZERLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 132. SWITZERLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 133. SWITZERLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 134. TURKEY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 135. TURKEY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 136. TURKEY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 137. UNITED ARAB EMIRATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 138. UNITED ARAB EMIRATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 139. UNITED ARAB EMIRATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 140. UNITED KINGDOM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
- TABLE 141. UNITED KINGDOM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
- TABLE 142. UNITED KINGDOM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 143. TOXICITY TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 144. TOXICITY TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023
